X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
index medicus (21) 21
male (20) 20
female (16) 16
atrial fibrillation (15) 15
stroke (15) 15
cardiac & cardiovascular systems (14) 14
aged (13) 13
middle aged (13) 13
management (10) 10
mortality (9) 9
risk factors (8) 8
warfarin (7) 7
abridged index medicus (6) 6
acute coronary syndromes (6) 6
atrial fibrillation - drug therapy (6) 6
cardiovascular disease (6) 6
care and treatment (6) 6
guidelines (6) 6
heart attacks (6) 6
hemorrhage (6) 6
patients (6) 6
prospective studies (6) 6
risk (6) 6
therapy (6) 6
adult (5) 5
aged, 80 and over (5) 5
anticoagulants (5) 5
anticoagulants - therapeutic use (5) 5
cardiovascular diseases (5) 5
death (5) 5
diagnosis (5) 5
double-blind method (5) 5
health risk assessment (5) 5
medicine, general & internal (5) 5
prevention (5) 5
registries (5) 5
stroke - prevention & control (5) 5
treatment outcome (5) 5
acute coronary syndrome (4) 4
alcohol (4) 4
analysis (4) 4
angina (4) 4
angina pectoris (4) 4
animals (4) 4
anticoagulants - adverse effects (4) 4
anticoagulation (4) 4
atrial fibrillation - complications (4) 4
cerebral infarction (4) 4
chromatography (4) 4
comorbidity (4) 4
diabetes (4) 4
follow-up studies (4) 4
heart diseases (4) 4
mice (4) 4
myocardial infarction (4) 4
outcomes (4) 4
pharmacology (4) 4
prevalence (4) 4
risk assessment (4) 4
statins (4) 4
stroke prevention (4) 4
surgery (4) 4
thromboembolism (4) 4
age (3) 3
antiplatelet therapy (3) 3
arrhythmia (3) 3
article (3) 3
atrial fibrillation - diagnosis (3) 3
atrial fibrillation - epidemiology (3) 3
atrial fibrillation - mortality (3) 3
behavior (3) 3
bleeding (3) 3
brain (3) 3
cardiac arrhythmia (3) 3
cardiology (3) 3
comparative analysis (3) 3
coronary artery disease (3) 3
drug dosages (3) 3
drug therapy (3) 3
embolism (3) 3
fibrillation (3) 3
garfield-af (3) 3
health risks (3) 3
heart failure (3) 3
heart-failure (3) 3
hemorrhage - chemically induced (3) 3
international normalized ratio (3) 3
ischemia (3) 3
liquid chromatography (3) 3
medicine (3) 3
multidisciplinary sciences (3) 3
myocardial-infarction (3) 3
oral anticoagulation (3) 3
patient outcomes (3) 3
pharmacology & pharmacy (3) 3
reduction (3) 3
registry (3) 3
research (3) 3
severity of illness index (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 22, pp. 2093 - 2104
Journal Article